HEADER TRANSCRIPTION 05-FEB-21 7NFB TITLE ER-PRS*(+) (Y537S) IN COMPLEX WITH GENISTEIN AND SRC-2 COACTIVATOR TITLE 2 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: C, D; COMPND 11 SYNONYM: NCOA-2,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75,BHLHE75, COMPND 12 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2,HTIF2; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS HUMAN ESTROGEN RECEPTOR ALPHA, HERA-LBD, GENISTEIN, SRC-2, LIGAND KEYWDS 2 BINDING DOMAIN, ER, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR M.KRIEGEL,Y.A.MULLER REVDAT 3 31-JAN-24 7NFB 1 REMARK REVDAT 2 26-OCT-22 7NFB 1 REMARK REVDAT 1 25-AUG-21 7NFB 0 JRNL AUTH M.KRIEGEL,H.J.WIEDERANDERS,S.ALKHASHROM,J.EICHLER,Y.A.MULLER JRNL TITL A PROSS-DESIGNED EXTENSIVELY MUTATED ESTROGEN RECEPTOR ALPHA JRNL TITL 2 VARIANT DISPLAYS ENHANCED THERMAL STABILITY WHILE RETAINING JRNL TITL 3 NATIVE ALLOSTERIC REGULATION AND STRUCTURE. JRNL REF SCI REP V. 11 10509 2021 JRNL REFN ESSN 2045-2322 JRNL PMID 34006920 JRNL DOI 10.1038/S41598-021-89785-1 REMARK 2 REMARK 2 RESOLUTION. 1.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.73 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 112460 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : 0.142 REMARK 3 FREE R VALUE : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.310 REMARK 3 FREE R VALUE TEST SET COUNT : 1469 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.7300 - 2.8600 0.98 11206 151 0.1388 0.1678 REMARK 3 2 2.8600 - 2.2700 1.00 11244 149 0.1251 0.1621 REMARK 3 3 2.2700 - 1.9900 1.00 11219 146 0.1062 0.1384 REMARK 3 4 1.9900 - 1.8100 0.97 10875 144 0.1214 0.1751 REMARK 3 5 1.8000 - 1.6800 0.99 11124 140 0.1341 0.1832 REMARK 3 6 1.6800 - 1.5800 1.00 11212 151 0.1539 0.2050 REMARK 3 7 1.5800 - 1.5000 1.00 11171 155 0.1881 0.2377 REMARK 3 8 1.5000 - 1.4300 0.99 11030 147 0.2325 0.2503 REMARK 3 9 1.4300 - 1.3800 0.97 10947 142 0.2845 0.3237 REMARK 3 10 1.3800 - 1.3300 0.98 10963 144 0.3125 0.3273 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.176 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.345 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.26 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4462 REMARK 3 ANGLE : 0.776 6026 REMARK 3 CHIRALITY : 0.053 682 REMARK 3 PLANARITY : 0.004 748 REMARK 3 DIHEDRAL : 18.052 1745 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7NFB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1292113841. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : DCM SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 112549 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.330 REMARK 200 RESOLUTION RANGE LOW (A) : 27.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.05818 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 2.09400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.840 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.17.1_3660 REMARK 200 STARTING MODEL: 7NEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM NACL, 100 MM TRIS PH 8.5 AND REMARK 280 25% POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.76300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 302 REMARK 465 MET A 303 REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER B 302 REMARK 465 MET B 303 REMARK 465 ASN B 304 REMARK 465 ACE C 685 REMARK 465 LYS C 686 REMARK 465 SER C 697 REMARK 465 SER C 698 REMARK 465 SER C 699 REMARK 465 SER D 697 REMARK 465 SER D 698 REMARK 465 SER D 699 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP B 351 O HOH B 701 1.95 REMARK 500 O2 EDO B 611 O HOH B 702 2.04 REMARK 500 O HOH B 877 O HOH B 879 2.05 REMARK 500 O HOH B 756 O HOH B 871 2.07 REMARK 500 OH TYR A 459 O HOH A 701 2.10 REMARK 500 OE2 GLU B 413 O HOH B 703 2.11 REMARK 500 O HOH A 726 O HOH A 863 2.12 REMARK 500 O HOH A 837 O HOH B 859 2.13 REMARK 500 O HOH A 793 O HOH A 866 2.13 REMARK 500 OD1 ASP B 351 OG SER B 537 2.16 REMARK 500 O HOH B 879 O HOH B 906 2.17 REMARK 500 OE1 GLU A 321 O HOH A 702 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 735 O HOH C 803 2645 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 918 DISTANCE = 7.26 ANGSTROMS REMARK 525 HOH D 705 DISTANCE = 6.70 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 602 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY A 400 O REMARK 620 2 HOH A 704 O 28.8 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7NEL RELATED DB: PDB REMARK 900 RELATED ID: 7NDO RELATED DB: PDB DBREF 7NFB A 304 548 UNP P03372 ESR1_HUMAN 304 548 DBREF 7NFB B 304 548 UNP P03372 ESR1_HUMAN 304 548 DBREF 7NFB C 686 699 UNP Q15596 NCOA2_HUMAN 686 699 DBREF 7NFB D 686 699 UNP Q15596 NCOA2_HUMAN 686 699 SEQADV 7NFB SER A 302 UNP P03372 EXPRESSION TAG SEQADV 7NFB MET A 303 UNP P03372 EXPRESSION TAG SEQADV 7NFB ILE A 315 UNP P03372 MET 315 ENGINEERED MUTATION SEQADV 7NFB ILE A 316 UNP P03372 VAL 316 ENGINEERED MUTATION SEQADV 7NFB GLU A 321 UNP P03372 ASP 321 ENGINEERED MUTATION SEQADV 7NFB SER A 334 UNP P03372 THR 334 ENGINEERED MUTATION SEQADV 7NFB TYR A 341 UNP P03372 SER 341 ENGINEERED MUTATION SEQADV 7NFB LYS A 363 UNP P03372 ARG 363 ENGINEERED MUTATION SEQADV 7NFB SER A 371 UNP P03372 THR 371 ENGINEERED MUTATION SEQADV 7NFB SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 7NFB ASP A 397 UNP P03372 GLU 397 ENGINEERED MUTATION SEQADV 7NFB ASP A 407 UNP P03372 ASN 407 ENGINEERED MUTATION SEQADV 7NFB GLU A 413 UNP P03372 ASN 413 ENGINEERED MUTATION SEQADV 7NFB SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 7NFB GLU A 433 UNP P03372 SER 433 ENGINEERED MUTATION SEQADV 7NFB GLU A 437 UNP P03372 MET 437 ENGINEERED MUTATION SEQADV 7NFB LYS A 439 UNP P03372 ASN 439 ENGINEERED MUTATION SEQADV 7NFB ARG A 442 UNP P03372 GLY 442 ENGINEERED MUTATION SEQADV 7NFB ALA A 450 UNP P03372 SER 450 ENGINEERED MUTATION SEQADV 7NFB ASN A 471 UNP P03372 GLU 471 ENGINEERED MUTATION SEQADV 7NFB GLU A 473 UNP P03372 ASP 473 ENGINEERED MUTATION SEQADV 7NFB LYS A 474 UNP P03372 HIS 474 ENGINEERED MUTATION SEQADV 7NFB MET A 478 UNP P03372 VAL 478 ENGINEERED MUTATION SEQADV 7NFB ALA A 485 UNP P03372 THR 485 ENGINEERED MUTATION SEQADV 7NFB TRP A 488 UNP P03372 HIS 488 ENGINEERED MUTATION SEQADV 7NFB TYR A 489 UNP P03372 LEU 489 ENGINEERED MUTATION SEQADV 7NFB SER A 493 UNP P03372 ALA 493 ENGINEERED MUTATION SEQADV 7NFB SER A 496 UNP P03372 THR 496 ENGINEERED MUTATION SEQADV 7NFB SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 7NFB SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 7NFB SER B 302 UNP P03372 EXPRESSION TAG SEQADV 7NFB MET B 303 UNP P03372 EXPRESSION TAG SEQADV 7NFB ILE B 315 UNP P03372 MET 315 ENGINEERED MUTATION SEQADV 7NFB ILE B 316 UNP P03372 VAL 316 ENGINEERED MUTATION SEQADV 7NFB GLU B 321 UNP P03372 ASP 321 ENGINEERED MUTATION SEQADV 7NFB SER B 334 UNP P03372 THR 334 ENGINEERED MUTATION SEQADV 7NFB TYR B 341 UNP P03372 SER 341 ENGINEERED MUTATION SEQADV 7NFB LYS B 363 UNP P03372 ARG 363 ENGINEERED MUTATION SEQADV 7NFB SER B 371 UNP P03372 THR 371 ENGINEERED MUTATION SEQADV 7NFB SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 7NFB ASP B 397 UNP P03372 GLU 397 ENGINEERED MUTATION SEQADV 7NFB ASP B 407 UNP P03372 ASN 407 ENGINEERED MUTATION SEQADV 7NFB GLU B 413 UNP P03372 ASN 413 ENGINEERED MUTATION SEQADV 7NFB SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 7NFB GLU B 433 UNP P03372 SER 433 ENGINEERED MUTATION SEQADV 7NFB GLU B 437 UNP P03372 MET 437 ENGINEERED MUTATION SEQADV 7NFB LYS B 439 UNP P03372 ASN 439 ENGINEERED MUTATION SEQADV 7NFB ARG B 442 UNP P03372 GLY 442 ENGINEERED MUTATION SEQADV 7NFB ALA B 450 UNP P03372 SER 450 ENGINEERED MUTATION SEQADV 7NFB ASN B 471 UNP P03372 GLU 471 ENGINEERED MUTATION SEQADV 7NFB GLU B 473 UNP P03372 ASP 473 ENGINEERED MUTATION SEQADV 7NFB LYS B 474 UNP P03372 HIS 474 ENGINEERED MUTATION SEQADV 7NFB MET B 478 UNP P03372 VAL 478 ENGINEERED MUTATION SEQADV 7NFB ALA B 485 UNP P03372 THR 485 ENGINEERED MUTATION SEQADV 7NFB TRP B 488 UNP P03372 HIS 488 ENGINEERED MUTATION SEQADV 7NFB TYR B 489 UNP P03372 LEU 489 ENGINEERED MUTATION SEQADV 7NFB SER B 493 UNP P03372 ALA 493 ENGINEERED MUTATION SEQADV 7NFB SER B 496 UNP P03372 THR 496 ENGINEERED MUTATION SEQADV 7NFB SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 7NFB SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 7NFB ACE C 685 UNP Q15596 ACETYLATION SEQADV 7NFB ACE D 685 UNP Q15596 ACETYLATION SEQRES 1 A 247 SER MET ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN SEQRES 2 A 247 ILE ILE SER ALA LEU LEU GLU ALA GLU PRO PRO ILE LEU SEQRES 3 A 247 TYR SER GLU TYR ASP PRO SER ARG PRO PHE SER GLU ALA SEQRES 4 A 247 TYR MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU SEQRES 5 A 247 LEU VAL HIS MET ILE ASN TRP ALA LYS LYS VAL PRO GLY SEQRES 6 A 247 PHE VAL ASP LEU SER LEU HIS ASP GLN VAL HIS LEU LEU SEQRES 7 A 247 GLU SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL SEQRES 8 A 247 TRP ARG SER MET ASP HIS PRO GLY LYS LEU LEU PHE ALA SEQRES 9 A 247 PRO ASP LEU LEU LEU ASP ARG GLU GLN GLY LYS SER VAL SEQRES 10 A 247 GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SEQRES 11 A 247 SER GLU ARG PHE ARG GLU MET LYS LEU GLN ARG GLU GLU SEQRES 12 A 247 PHE VAL CYS LEU LYS ALA ILE ILE LEU LEU ASN SER GLY SEQRES 13 A 247 VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU SEQRES 14 A 247 ASN LYS GLU LYS ILE HIS ARG MET LEU ASP LYS ILE THR SEQRES 15 A 247 ASP ALA LEU ILE TRP TYR MET ALA LYS SER GLY LEU SER SEQRES 16 A 247 LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU SEQRES 17 A 247 ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET SEQRES 18 A 247 GLU HIS LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO SEQRES 19 A 247 LEU SER ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 1 B 247 SER MET ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN SEQRES 2 B 247 ILE ILE SER ALA LEU LEU GLU ALA GLU PRO PRO ILE LEU SEQRES 3 B 247 TYR SER GLU TYR ASP PRO SER ARG PRO PHE SER GLU ALA SEQRES 4 B 247 TYR MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU SEQRES 5 B 247 LEU VAL HIS MET ILE ASN TRP ALA LYS LYS VAL PRO GLY SEQRES 6 B 247 PHE VAL ASP LEU SER LEU HIS ASP GLN VAL HIS LEU LEU SEQRES 7 B 247 GLU SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL SEQRES 8 B 247 TRP ARG SER MET ASP HIS PRO GLY LYS LEU LEU PHE ALA SEQRES 9 B 247 PRO ASP LEU LEU LEU ASP ARG GLU GLN GLY LYS SER VAL SEQRES 10 B 247 GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SEQRES 11 B 247 SER GLU ARG PHE ARG GLU MET LYS LEU GLN ARG GLU GLU SEQRES 12 B 247 PHE VAL CYS LEU LYS ALA ILE ILE LEU LEU ASN SER GLY SEQRES 13 B 247 VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU SEQRES 14 B 247 ASN LYS GLU LYS ILE HIS ARG MET LEU ASP LYS ILE THR SEQRES 15 B 247 ASP ALA LEU ILE TRP TYR MET ALA LYS SER GLY LEU SER SEQRES 16 B 247 LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU SEQRES 17 B 247 ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET SEQRES 18 B 247 GLU HIS LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO SEQRES 19 B 247 LEU SER ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 1 C 15 ACE LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SEQRES 2 C 15 SER SER SEQRES 1 D 15 ACE LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER SEQRES 2 D 15 SER SER HET ACE D 685 3 HET GEN A 601 30 HET NA A 602 1 HET NA A 603 1 HET EDO A 604 10 HET EDO A 605 10 HET EDO A 606 10 HET EDO A 607 10 HET EDO A 608 10 HET EDO A 609 10 HET EDO A 610 10 HET CL A 611 1 HET GEN B 601 30 HET NA B 602 1 HET EDO B 603 10 HET EDO B 604 10 HET EDO B 605 10 HET EDO B 606 10 HET EDO B 607 10 HET EDO B 608 10 HET EDO B 609 10 HET EDO B 610 10 HET EDO B 611 10 HET CL B 612 1 HET CL B 613 1 HET GOL C 701 14 HETNAM ACE ACETYL GROUP HETNAM GEN GENISTEIN HETNAM NA SODIUM ION HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETNAM GOL GLYCEROL HETSYN GEN 5,7-DIHYDROXY-3-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4- HETSYN 2 GEN ONE; 4',5,7-TRIHYDROXYISOFLAVONE; PRUNETOL; GENISTEOL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 ACE C2 H4 O FORMUL 5 GEN 2(C15 H10 O5) FORMUL 6 NA 3(NA 1+) FORMUL 8 EDO 16(C2 H6 O2) FORMUL 15 CL 3(CL 1-) FORMUL 29 GOL C3 H8 O3 FORMUL 30 HOH *435(H2 O) HELIX 1 AA1 LEU A 306 LEU A 310 5 5 HELIX 2 AA2 THR A 311 ALA A 322 1 12 HELIX 3 AA3 SER A 338 VAL A 364 1 27 HELIX 4 AA4 GLY A 366 LEU A 370 5 5 HELIX 5 AA5 SER A 371 MET A 396 1 26 HELIX 6 AA6 ASP A 411 LYS A 416 1 6 HELIX 7 AA7 GLY A 420 LYS A 439 1 20 HELIX 8 AA8 GLN A 441 SER A 456 1 16 HELIX 9 AA9 THR A 465 SER A 493 1 29 HELIX 10 AB1 SER A 496 LYS A 531 1 36 HELIX 11 AB2 SER A 537 ALA A 546 1 10 HELIX 12 AB3 LEU B 306 LEU B 310 5 5 HELIX 13 AB4 THR B 311 ALA B 322 1 12 HELIX 14 AB5 SER B 338 LYS B 362 1 25 HELIX 15 AB6 GLY B 366 LEU B 370 5 5 HELIX 16 AB7 SER B 371 MET B 396 1 26 HELIX 17 AB8 ARG B 412 LYS B 416 1 5 HELIX 18 AB9 GLY B 420 LYS B 439 1 20 HELIX 19 AC1 GLN B 441 SER B 456 1 16 HELIX 20 AC2 THR B 465 SER B 493 1 29 HELIX 21 AC3 SER B 496 LYS B 531 1 36 HELIX 22 AC4 SER B 537 ALA B 546 1 10 HELIX 23 AC5 LYS C 688 LEU C 694 1 7 HELIX 24 AC6 LYS D 688 ASP D 696 1 9 SHEET 1 AA1 2 LEU A 402 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 LEU A 410 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C ACE D 685 N LYS D 686 1555 1555 1.33 LINK O GLY A 400 NA NA B 602 1555 2646 3.15 LINK O LEU A 497 NA NA A 602 1555 1555 2.90 LINK NA NA A 603 O HOH A 829 1555 1555 2.75 LINK O HOH A 704 NA NA B 602 2656 1555 2.89 CRYST1 55.854 81.526 58.464 90.00 108.46 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017904 0.000000 0.005976 0.00000 SCALE2 0.000000 0.012266 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018032 0.00000